Medical professionals around the world use BinaxNOW® rapid in vitro diagnostic tests to identify a variety of infectious diseases at the point of care. Our technologies detect bacteria and viruses causing upper and lower respiratory tract infections, including Legionnaires' disease, pneumonia, RSV and influenza, as well as pathogens causing filariasis and malaria.
Rapid and accurate test results provide the foundation for pathogen-specific diagnosis, facilitating optimal patient management and infection control practices.
Alere BinaxNOW® Legionella Urinary Antigen Test is a rapid assay for the qualitative detection of Legionella pneumophila serogroup 1 antigen in urine samples from patients with symptoms of pneumonia.
Alere BinaxNOW® S. pneumoniae is a rapid assay for the qualitative detection of S. pneumoniae antigen in the urine of patients with pneumonia and in the cerebral spinal fluid (CSF) of patients with meningitis.
Alere BinaxNOW® Influenza A & B is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab, nasal swab samples and nasal wash/aspirate specimens.
Alere BinaxNOW® RSV is an in vitro rapid immunochromatographic assay used to detect respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal (NP) swab specimens from symptomatic patients.
The BinaxNOW® Malaria test is an in vitro immunochromatographic assay for the qualitative detection of Plasmodium antigens circulating in human venous and capillary EDTA whole blood of individuals with signs and symptoms of malarial infection.